EUCTR2011-000842-39-IT进行中（未招募）不适用
A Comparison of LY2605541 versus Insulin Glargine as Basal Insulin Treatment in Combination with Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study The IMAGINE 2 Study - IMAGINE 2
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ELI LILLY
- 入组人数
- 1,516
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •T2DM (per World Health Organization [WHO] Classification of Diabetes not treated with insulin [2] Age 18 years of age or older [3] Duration of diabetes = 1 year
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1137
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 379
排除标准
- •Insulin therapy: have used insulin therapy (outside of pregnancy) anytime in the past 2 years, except for short term treatment of acute conditions, and up to a maximum of 4 continuous weeks. [13] Concomitant medications: Rosiglitazone, glucagon-like peptide-1 (GLP-1) receptor agonist (for example, exenatide, exenatide onceweekly or liraglutide) used concurrently or within 3 months prior to screening. [14] Local OAM restrictions: for patients on OAMs, restrictions for cardiac, renal and hepatic diseases, local product regulations must apply [15] Prescription weight loss medications: are currently taking, or have taken within the 3 months preceding screening, prescription or over-thecounter medications to promote weight loss. [16] Severe hypoglycemia history
研究者
相似试验
进行中（未招募）
不适用
A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetesType 2 Diabetes MellitusEUCTR2011-005866-39-DEEli Lilly and Company426
进行中（未招募）
1 期
A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2011-005866-39-CZEli Lilly and Company426
进行中（未招募）
1 期
A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2011-005866-39-ESilly S.A.466
进行中（未招募）
不适用
A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2011-005866-39-GREli Lilly and Company426
Unknown
3 期
A Study of Insulin Peglispro in Participants With Type 2 Diabetes MellitusCTRI/2014/09/005054Eli Lilly and Company663